Menu

How Dogs Interpret Speech

Dogs tend to turn to the left when they hear emotional speech-like sounds, and right when they hear verbal commands from a robot.

Dec 2, 2014
Jef Akst

WIKIMEDIA, ILDAR SAGDEJEVUsing head movements to extrapolate which half of the brain dogs use to interpret verbal input, researchers have uncovered evidence that man’s best friend may show similar patterns of processing human speech as their owners do, according to a study published last week (November 26) in Current Biology.

When presented with a monotone, robotic voice speaking the familiar command “to come” from speakers on both sides of the dogs’ heads, the animals tended to turn to the right, suggesting their left hemispheres were at work. Upon hearing meaningless jibber-jabber chock-full of emotion, the dogs tended to turn to the left, indicating use of their right hemispheres. In humans, the left hemisphere is generally associated with speech processing, while the right is associated with picking up emotional cues, though both hemispheres play a role in different stages of speech interpretation.

The study also suggested that dogs key into the meaning of words, not just the inflection with which humans say them, Attila Andics, a neurobiologist at the MTA-ELTE Comparative Ethology Research Group in Budapest, told NPR’s Shots. “[The] dogs are able to differentiate between meaningful and meaningless sound sequences.”

Recent research has also suggested that dogs—unlike most other animals, including chimps—can understand the intentions behind human pointing.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.